Market Research Logo

Pharmaceuticals in Germany

Pharmaceuticals in Germany

Summary

Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Germany pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The German pharmaceuticals market had total revenues of $71.3bn in 2017, representing a compound annual growth rate (CAGR) of 7.1% between 2013 and 2017.
  • Infrastructure support in Germany is strong for both foreign and domestic companies, which has encouraged investment in research and development centres and the construction of new manufacturing plants.
  • An aging population should serve to increase spending; however, governments are under pressure to keep a lid on spending, potentially constraining growth in the market.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Germany
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts
Reasons to buy
  • What was the size of the Germany pharmaceuticals market by value in 2017?
  • What will be the size of the Germany pharmaceuticals market in 2022?
  • What factors are affecting the strength of competition in the Germany pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Germany's pharmaceuticals market?


Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Boehringer Ingelheim GmbH
Novartis AG
F. Hoffmann-La Roche Ltd
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Germany pharmaceuticals market value: $ billion, 2013-17
Table 2: Germany pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: Germany pharmaceuticals market share: % share, by value, 2017
Table 4: Germany pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: Bayer AG: key facts
Table 6: Bayer AG: key financials ($)
Table 7: Bayer AG: key financials (€)
Table 8: Bayer AG: key financial ratios
Table 9: Boehringer Ingelheim GmbH: key facts
Table 10: Boehringer Ingelheim GmbH: key financials ($)
Table 11: Boehringer Ingelheim GmbH: key financials (€)
Table 12: Boehringer Ingelheim GmbH: key financial ratios
Table 13: Novartis AG: key facts
Table 14: Novartis AG: key financials ($)
Table 15: Novartis AG: key financial ratios
Table 16: F. Hoffmann-La Roche Ltd: key facts
Table 17: F. Hoffmann-La Roche Ltd: key financials ($)
Table 18: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 19: F. Hoffmann-La Roche Ltd: key financial ratios
Table 20: Germany size of population (million), 2013-17
Table 21: Germany gdp (constant 2005 prices, $ billion), 2013-17
Table 22: Germany gdp (current prices, $ billion), 2013-17
Table 23: Germany inflation, 2013-17
Table 24: Germany consumer price index (absolute), 2013-17
Table 25: Germany exchange rate, 2013-17
List of Figures
Figure 1: Germany pharmaceuticals market value: $ billion, 2013-17
Figure 2: Germany pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: Germany pharmaceuticals market share: % share, by value, 2017
Figure 4: Germany pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the pharmaceuticals market in Germany, 2017
Figure 6: Drivers of buyer power in the pharmaceuticals market in Germany, 2017
Figure 7: Drivers of supplier power in the pharmaceuticals market in Germany, 2017
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2017
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2017
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2017
Figure 11: Bayer AG: revenues & profitability
Figure 12: Bayer AG: assets & liabilities
Figure 13: Boehringer Ingelheim GmbH: revenues & profitability
Figure 14: Boehringer Ingelheim GmbH: assets & liabilities
Figure 15: Novartis AG: revenues & profitability
Figure 16: Novartis AG: assets & liabilities
Figure 17: F. Hoffmann-La Roche Ltd: revenues & profitability
Figure 18: F. Hoffmann-La Roche Ltd: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report